Search

Nita M. Minnifield

Examiner (ID: 3839, Phone: (571)272-0860 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645, 1621, 1813, 1802, 1817
Total Applications
1564
Issued Applications
1017
Pending Applications
126
Abandoned Applications
425

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7468110 [patent_doc_number] => 20040120966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof' [patent_app_type] => new [patent_app_number] => 10/751702 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20509 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120966.pdf [firstpage_image] =>[orig_patent_app_number] => 10751702 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/751702
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof Jan 4, 2004 Issued
Array ( [id] => 7502404 [patent_doc_number] => 08034378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Immunogenic compositions containing phospholipid' [patent_app_type] => utility [patent_app_number] => 10/748117 [patent_app_country] => US [patent_app_date] => 2003-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16833 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034378.pdf [firstpage_image] =>[orig_patent_app_number] => 10748117 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/748117
Immunogenic compositions containing phospholipid Dec 28, 2003 Issued
Array ( [id] => 7199832 [patent_doc_number] => 20040086558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Liposome mediated dna administration' [patent_app_type] => new [patent_app_number] => 10/468571 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5186 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086558.pdf [firstpage_image] =>[orig_patent_app_number] => 10468571 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/468571
Liposome mediated dna administration Dec 22, 2003 Abandoned
Array ( [id] => 7336877 [patent_doc_number] => 20040132685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Immunostimulatory nucleic acid' [patent_app_type] => new [patent_app_number] => 10/743625 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21901 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132685.pdf [firstpage_image] =>[orig_patent_app_number] => 10743625 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/743625
Immunostimulatory nucleic acid Dec 21, 2003 Abandoned
Array ( [id] => 82259 [patent_doc_number] => 07745606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Immunostimulatory sequence oligonucleotides and methods of using the same' [patent_app_type] => utility [patent_app_number] => 10/741720 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 44562 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745606.pdf [firstpage_image] =>[orig_patent_app_number] => 10741720 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/741720
Immunostimulatory sequence oligonucleotides and methods of using the same Dec 17, 2003 Issued
Array ( [id] => 4493373 [patent_doc_number] => 07956043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-07 [patent_title] => '5′ CpG nucleic acids and methods of use' [patent_app_type] => utility [patent_app_number] => 10/735592 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22169 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/956/07956043.pdf [firstpage_image] =>[orig_patent_app_number] => 10735592 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/735592
5′ CpG nucleic acids and methods of use Dec 10, 2003 Issued
Array ( [id] => 5705263 [patent_doc_number] => 20060194311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Lna-cpg conjugates' [patent_app_type] => utility [patent_app_number] => 10/538129 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9934 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194311.pdf [firstpage_image] =>[orig_patent_app_number] => 10538129 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/538129
Lna-cpg conjugates Dec 3, 2003 Abandoned
Array ( [id] => 7224024 [patent_doc_number] => 20050261215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Methods and immune modulatory nucleic acid compositions for preventing and treating disease' [patent_app_type] => utility [patent_app_number] => 10/524643 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 27114 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261215.pdf [firstpage_image] =>[orig_patent_app_number] => 10524643 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/524643
Methods and immune modulatory nucleic acid compositions for preventing and treating disease Nov 20, 2003 Issued
Array ( [id] => 7183015 [patent_doc_number] => 20040203026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Biologically active bactericidal/permeability-increasing protein fragments' [patent_app_type] => new [patent_app_number] => 10/716389 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7446 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203026.pdf [firstpage_image] =>[orig_patent_app_number] => 10716389 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/716389
Biologically active bactericidal/permeability-increasing protein fragments Nov 17, 2003 Abandoned
Array ( [id] => 7256362 [patent_doc_number] => 20050075496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Plasmodium falciparum antigens and their vaccine and diagnostic applications' [patent_app_type] => utility [patent_app_number] => 10/712533 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16621 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075496.pdf [firstpage_image] =>[orig_patent_app_number] => 10712533 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/712533
Plasmodium falciparum antigens and their vaccine and diagnostic applications Nov 13, 2003 Issued
Array ( [id] => 442079 [patent_doc_number] => 07255867 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-14 [patent_title] => 'Vaccine' [patent_app_type] => utility [patent_app_number] => 10/706275 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 28 [patent_no_of_words] => 11436 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/255/07255867.pdf [firstpage_image] =>[orig_patent_app_number] => 10706275 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/706275
Vaccine Nov 12, 2003 Issued
Array ( [id] => 7333563 [patent_doc_number] => 20040131694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutic application' [patent_app_type] => new [patent_app_number] => 10/697264 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7489 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131694.pdf [firstpage_image] =>[orig_patent_app_number] => 10697264 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/697264
Pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutic application Oct 30, 2003 Abandoned
Array ( [id] => 4618778 [patent_doc_number] => 07998492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Methods and products related to treatment and prevention of hepatitis C virus infection' [patent_app_type] => utility [patent_app_number] => 10/532746 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 25924 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998492.pdf [firstpage_image] =>[orig_patent_app_number] => 10532746 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/532746
Methods and products related to treatment and prevention of hepatitis C virus infection Oct 28, 2003 Issued
Array ( [id] => 4570886 [patent_doc_number] => 07824696 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes' [patent_app_type] => utility [patent_app_number] => 10/694418 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 56 [patent_no_of_words] => 9059 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824696.pdf [firstpage_image] =>[orig_patent_app_number] => 10694418 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/694418
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes Oct 26, 2003 Issued
Array ( [id] => 7467979 [patent_doc_number] => 20040198951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof' [patent_app_type] => new [patent_app_number] => 10/680349 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12530 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198951.pdf [firstpage_image] =>[orig_patent_app_number] => 10680349 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/680349
Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof Oct 6, 2003 Abandoned
Array ( [id] => 7308776 [patent_doc_number] => 20040142399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Recombinant FlaA as a diagnostic reagent' [patent_app_type] => new [patent_app_number] => 10/675447 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6790 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142399.pdf [firstpage_image] =>[orig_patent_app_number] => 10675447 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/675447
Recombinant FlaA as a diagnostic reagent Sep 29, 2003 Abandoned
Array ( [id] => 623164 [patent_doc_number] => 07138115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 10/659586 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 6515 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138115.pdf [firstpage_image] =>[orig_patent_app_number] => 10659586 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/659586
Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases Sep 10, 2003 Issued
Array ( [id] => 7150799 [patent_doc_number] => 20040171525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Method of using lectins for prevention and treatment of oral and alimentary tract disorders' [patent_app_type] => new [patent_app_number] => 10/654104 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7657 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171525.pdf [firstpage_image] =>[orig_patent_app_number] => 10654104 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/654104
Method of using lectins for prevention and treatment of oral and alimentary tract disorders Sep 2, 2003 Abandoned
Array ( [id] => 6966051 [patent_doc_number] => 20050232948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Adjuvanted vaccine which is substantially free of non-host albumin' [patent_app_type] => utility [patent_app_number] => 10/654534 [patent_app_country] => US [patent_app_date] => 2003-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9048 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232948.pdf [firstpage_image] =>[orig_patent_app_number] => 10654534 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/654534
Process for making an adjuvanted vaccine comprising host albumin Sep 1, 2003 Issued
Array ( [id] => 545034 [patent_doc_number] => 07166708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Process for preparing conjugate vaccines and the conjugate vaccines' [patent_app_type] => utility [patent_app_number] => 10/650786 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7295 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166708.pdf [firstpage_image] =>[orig_patent_app_number] => 10650786 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/650786
Process for preparing conjugate vaccines and the conjugate vaccines Aug 28, 2003 Issued
Menu